Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 10799894)

1.

Structural analysis of CTLA-4 function in vivo.

Masteller EL, Chuang E, Mullen AC, Reiner SL, Thompson CB.

J Immunol. 2000 May 15;164(10):5319-27.

2.

Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.

Yi LA, Hajialiasgar S, Chuang E.

Int Immunol. 2004 Apr;16(4):539-47.

3.

The role of CTLA-4 in regulating Th2 differentiation.

Oosterwegel MA, Mandelbrot DA, Boyd SD, Lorsbach RB, Jarrett DY, Abbas AK, Sharpe AH.

J Immunol. 1999 Sep 1;163(5):2634-9.

4.

Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice.

Hwang KW, Sweatt WB, Mashayekhi M, Palucki DA, Sattar H, Chuang E, Alegre ML.

J Immunol. 2004 Nov 1;173(9):5415-24.

5.

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH.

Immunity. 1995 Nov;3(5):541-7.

PMID:
7584144
6.

Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.

Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA.

J Immunol. 1999 May 15;162(10):5784-91.

7.
9.

Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function.

Stumpf M, Zhou X, Chikuma S, Bluestone JA.

Eur J Immunol. 2014 Jun;44(6):1737-46. doi: 10.1002/eji.201343891. Epub 2014 Apr 15.

10.

Cutting edge: two distinct mechanisms lead to impaired T cell homeostasis in Janus kinase 3- and CTLA-4-deficient mice.

Gozalo-Sanmillan S, McNally JM, Lin MY, Chambers CA, Berg LJ.

J Immunol. 2001 Jan 15;166(2):727-30.

11.

Expression and function of CTLA-4 in Th1 and Th2 cells.

Alegre ML, Shiels H, Thompson CB, Gajewski TF.

J Immunol. 1998 Oct 1;161(7):3347-56.

15.

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW.

Science. 1995 Nov 10;270(5238):985-8.

PMID:
7481803
16.

Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.

Sho M, Yamada A, Najafian N, Salama AD, Harada H, Sandner SE, Sanchez-Fueyo A, Zheng XX, Strom TB, Sayegh MH.

J Immunol. 2002 Oct 1;169(7):3744-51.

17.

Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.

Sakurai J, Ohata J, Saito K, Miyajima H, Hirano T, Kohsaka T, Enomoto S, Okumura K, Azuma M.

J Immunol. 2000 Jan 15;164(2):664-9.

18.

Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4.

Cinek T, Sadra A, Imboden JB.

J Immunol. 2000 Jan 1;164(1):5-8.

19.

Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.

Bonham CA, Peng L, Liang X, Chen Z, Wang L, Ma L, Hackstein H, Robbins PD, Thomson AW, Fung JJ, Qian S, Lu L.

J Immunol. 2002 Sep 15;169(6):3382-91.

20.

B7-independent inhibition of T cells by CTLA-4.

Chikuma S, Abbas AK, Bluestone JA.

J Immunol. 2005 Jul 1;175(1):177-81.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk